Treatment of cancer with lymphokine-activated killer cells and interleukin-2.
D006801:Humans; D007376:Interleukin-2 / Q000276:immunology / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology*; D008213:Lymphocyte Activation; D008222:Lymphokines / Q000276:immunology*; D009369:Neoplasms / Q000628:therapy*
D007376:Interleukin-2; D008222:Lymphokines